Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
38.79
+0.17 (0.44%)
At close: Jul 19, 2024, 4:00 PM
39.01
+0.22 (0.57%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

CALT Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018
Revenue
1,2071,207802.88229.350.87184.83
Upgrade
Revenue Growth (YoY)
-50.32%250.07%26141.08%-99.53%-
Upgrade
Cost of Revenue
60.4660.4615.2000
Upgrade
Gross Profit
1,1461,146787.68229.350.87184.83
Upgrade
Selling, General & Admin
1,0611,061774.66390.23141.7262.88
Upgrade
Research & Development
502.22502.22414.75357.49241.37149.83
Upgrade
Other Operating Expenses
-43.47-43.4720.216.09-2.50.14
Upgrade
Operating Expenses
1,5191,5191,210753.8380.59212.85
Upgrade
Operating Income
-373.06-373.06-421.94-524.46-379.72-28.02
Upgrade
Interest Expense / Income
114.35114.3537.679.2556.985.41
Upgrade
Other Expense / Income
-30.39-30.39-50.19-29.58-3.56-0.93
Upgrade
Pretax Income
-457.02-457.02-409.42-504.13-433.13-32.5
Upgrade
Income Tax
9.179.172.85-3.840.360.08
Upgrade
Net Income
-466.19-466.19-412.27-500.29-433.49-32.58
Upgrade
Shares Outstanding (Basic)
606059504646
Upgrade
Shares Change
19.30%0.80%18.35%7.88%--
Upgrade
EPS (Basic)
-17.38-17.38-15.56-19.68-19.32-1.76
Upgrade
EPS (Diluted)
-17.38-17.38-15.56-19.68-19.32-1.76
Upgrade
Free Cash Flow
-447.44-447.44-313.87-468.18-309.18-71.13
Upgrade
Free Cash Flow Per Share
-15.02-15.02-10.62-18.75-13.36-3.07
Upgrade
Gross Margin
94.99%94.99%98.11%100.00%100.00%100.00%
Upgrade
Operating Margin
-30.91%-30.91%-52.55%-228.67%-43446.22%-15.16%
Upgrade
Profit Margin
-38.63%-38.63%-51.35%-218.14%-49598.86%-17.63%
Upgrade
Free Cash Flow Margin
-37.07%-37.07%-39.09%-204.13%-35375.40%-38.48%
Upgrade
EBITDA
-342.67-342.67-371.75-494.88-376.16-27.09
Upgrade
EBITDA Margin
-28.39%-28.39%-46.30%-215.78%-43038.44%-14.66%
Upgrade
EBIT
-342.67-342.67-371.75-494.88-376.16-27.09
Upgrade
EBIT Margin
-28.39%-28.39%-46.30%-215.78%-43038.44%-14.66%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).